Estrogen plus Progestin reduces the risk of fractures regardless of risk factors: The Women's Health Initiative.

被引：0

作者：

Watts, NB ^{[1
]}

Robbins, J ^{[1
]}

Chen, Z ^{[1
]}

Cummings, SR ^{[1
]}

Jackson, R ^{[1
]}

LaCroix, A ^{[1
]}

LeBoff, M ^{[1
]}

Lewis, CE ^{[1
]}

McGowan, J ^{[1
]}

Neuner, J ^{[1
]}

Pettinger, J ^{[1
]}

Stefanick, M ^{[1
]}

Wactawski-Wende, J ^{[1
]}

Cauley, JA ^{[1
]}

机构：

[1] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA

来源：

JOURNAL OF BONE AND MINERAL RESEARCH | 2003年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S93 / S93

页数：1

共 50 条

[21] Women's experiences after abruptly stopping estrogen plus progestin in the Women's Health Initiative clinical trial
Cooksey, SG
Ritenbaugh, CK
Valanis, BG
Brandon, PL
Siegel, NA
Smith, PR
Aickin, MG
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2003, 10 (06): : 569 - 569
[22] Increased Risk of Hip Fractures in Postmenopausal Women with Moderate-Severe Pelvic Organ Prolapse: Analysis of Data from the Women's Health Initiative Estrogen Plus Progestin (WHI E Plus P) Trial
Pal, Lubna
Hailpern, Susan M.
Santoro, Nanette F.
Freeman, Ruth
Barad, David
Kipersztok, Simon
Barnabei, Vanessa M.
Wassertheil-Smoller, Sylvia
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (06): : 1205 - 1205
[23] What pharmacists need to know about the Women's Health Initiative Estrogen plus Progestin trial
Saseen, JJ
Hansen, LB
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (03) : 281 - 284
[24] Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial
Chlebowski, R. T.
Anderson, G. L.
Sarto, G. E.
Haque, R.
Runowicz, C. D.
Aragaki, A. K.
Thomson, C. A.
Howard, B. V.
Wactawski-Wende, J.
Chen, C.
Rohan, T. E.
Simon, M. S.
Reed, S. D.
Manson, J. E.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (03):
[25] Association of pelvic organ prolapse and fractures in postmenopausal women: analysis of baseline data from the Women's Health Initiative Estrogen Plus Progestin trial
Pal, Lubna
Hailpern, Susan M.
Santoro, Nanette F.
Freeman, Ruth
Barad, David
Kipersztok, Simon
Barnabei, Vanessa M.
Wassertheil-Smoller, Sylvia
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (01): : 59 - 66
[26] INFERTILITY AND RISK OF CARDIOVASCULAR DISEASE AMONG POSTMENOPAUSAL PARTICIPANTS IN THE WOMEN'S HEALTH INITIATIVE.
Murugappan, Gayathree
Leonard, Stephanie A.
Carmichael, Suzan L.
Stefanick, Marcia L.
Parikh, Nisha I.
FERTILITY AND STERILITY, 2021, 116 (03) : E15 - E15
[27] Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative Randomized Trial
McTiernan, A
Martin, CF
Peck, JD
Aragaki, AK
Chlebowski, RT
Pisano, ED
Wang, CY
Brunner, RL
Johnson, KC
Manson, JE
Lewis, CE
Kotchen, JM
Hulka, BS
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (18): : 1366 - 1376
[28] The influence of postmenopausal Estrogen/Progestin therapy on glucose and insulin concentrations and the risk of diabetes in postmenopausal women-the women's health initiative
Howard, B
Margolis, K
Allen, C
Bassford, T
Bonds, D
Burke, G
Phillips, L
Rodabough, R
Tinker, L
Torrens, J
DIABETES, 2003, 52 : A142 - A142
[29] HORMONE THERAPY REDUCES THE RISK OF FRACTURE REGARDLESS OF BASELINE FRACTURE RISK: RESULTS FROM THE WOMEN'S HEALTH INITIATIVE HORMONE THERAPY TRIALS
Lorentzon, M.
Johansson, H.
Harvey, N.
Liu, E.
Crandall, C.
Mccloskey, E.
Kanis, J.
OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S280 - S281
[30] Endogenous sex hormones and risk of coronary heart disease in postmenopausal women in the Women's Health Initiative.
Rexrode, KM
Hankinson, SE
McTiernan, A
Stefanick, M
Heckbert, SR
Hendrix, SL
Kuller, L
Manson, JE
CIRCULATION, 2004, 109 (07) : E76 - E76

← 1 2 3 4 5 →